Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 Variants

ABSTRACT: Reliable immunoassays are essential to early predict and monitor vaccine efficacy against SARS-CoV-2. The performance of an Interferon Gamma Release Assay (IGRA, QuantiFERON® SARS-CoV-2), and a current anti-spike serological test, compared to a plaque reduction neutralization test (PRNT) t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogrig, Manon, Berger, Anne-Emmanuelle, Bourlet, Thomas, Waeckel, Louis, Haccourt, Alice, Chanavat, Alice, Hupin, David, Roche, Frederic, Botelho-Nevers, Elisabeth, Pozzetto, Bruno, Paul, Stéphane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403229/
https://www.ncbi.nlm.nih.gov/pubmed/36006568
http://dx.doi.org/10.1007/s10875-022-01354-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403229/
https://www.ncbi.nlm.nih.gov/pubmed/36006568
http://dx.doi.org/10.1007/s10875-022-01354-x

Ejemplares similares